Tax-funded, public drug reimbursement plans are focused primarily on cost-containment. The Cameron Institute proposes that any catastrophic drug coverage plan not be centred on cost containment but rather the people-focused principles of comprehensiveness, universality, accessibility, efficiency, effectiveness and safety.